Efficacy and safety of intravitreal anti-VEGF therapy in diabetic retinopathy: what we have learned and what should we learn further?

Uludag, Gunay; Hassan, Muhammad; Matsumiya, Wataru; Pham, Brandon Huy; Chea, Sophaktra; Trong Tuong Than, Ngoc; Doan, Hien Luong; Akhavanrezayat, Amir; Halim, Muhammad Sohail; Do, Diana V; Nguyen, Quan Dong

Uludag, Gunay; Hassan, Muhammad; Matsumiya, Wataru; Pham, Brandon Huy; Chea, Sophaktra; Trong Tuong Than, Ngoc; Doan, Hien Luong; Akhavanrezayat, Amir; Halim, Muhammad Sohail; Do, Diana V; Nguyen, Quan Dong.

Afiliação

Uludag G; Byers Eye Institute, Stanford University, Palo Alto, CA, USA.
Hassan M; Byers Eye Institute, Stanford University, Palo Alto, CA, USA.
Matsumiya W; Byers Eye Institute, Stanford University, Palo Alto, CA, USA.
Pham BH; Department of Surgery, Division of Ophthalmology, Kobe University Graduate School of Medicine, Kobe, Japan.
Chea S; Byers Eye Institute, Stanford University, Palo Alto, CA, USA.
Trong Tuong Than N; Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami, Miami, FL, USA.
Doan HL; Byers Eye Institute, Stanford University, Palo Alto, CA, USA.
Akhavanrezayat A; Byers Eye Institute, Stanford University, Palo Alto, CA, USA.
Halim MS; Byers Eye Institute, Stanford University, Palo Alto, CA, USA.
Do DV; Byers Eye Institute, Stanford University, Palo Alto, CA, USA.
Nguyen QD; Byers Eye Institute, Stanford University, Palo Alto, CA, USA.

Expert Opin Biol Ther ; 22(10): 1275-1291, 2022 10.

Article em En | MEDLINE | ID: mdl-35818801

Assuntos

Diabetes Mellitus; Retinopatia Diabética; Edema Macular; Humanos; Retinopatia Diabética/tratamento farmacológico; Ranibizumab; Edema Macular/tratamento farmacológico; Edema Macular/etiologia; Bevacizumab/uso terapêutico; Fator A de Crescimento do Endotélio Vascular; Inibidores da Angiogênese/efeitos adversos; Receptores de Fatores de Crescimento do Endotélio Vascular; Anticorpos Monoclonais/uso terapêutico; Proteínas Recombinantes de Fusão/efeitos adversos; Injeções Intravítreas

Palavras-chave

Aflibercept; anti-vascular endothelial growth factor; bevacizumab; diabetic macular edema; diabetic retinopathy; ranibizumab; vascular endothelial growth factor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Edema Macular / Diabetes Mellitus / Retinopatia Diabética Tipo de estudo: Etiology_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google